BSGI/MBI Continues to Gain Valuable Recognition in Breast Cancer Detection: RSNA 2010 | RSNA 2010
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

Live From RSNA 2010

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

BSGI/MBI Continues to Gain Valuable Recognition in Breast Cancer Detection: RSNA 2010

Medical Conferences News - RSNA 2010

More than ten BSGI/MBI educational exhibits will be presented at the 2010 Radiological Society of North America ( RSNA-2010 ) annual meeting in Chicago.

Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) is gaining momentum as a standard of care in the diagnostic work up of patients. More than ten BSGI/MBI educational exhibits will be presented at the 2010 Radiological Society of North America ( RSNA-2010 ) annual meeting in Chicago next week. These upcoming presentations, along with others at radiology, surgical and breast disease medical society meetings all around the world, continue to demonstrate the viability of the technology as an important diagnostic tool for early breast cancer detection. In addition, the Society of Nuclear Medicine (SNM) recently released a nuclear medicine breast imaging protocol that includes specific procedural guidelines and clinical indications for conducting BSGI/MBI.

BSGI/MBI is especially useful in difficult-to-diagnose cases such as Ductal Carcinoma in Situ (DCIS), where mammography may not accurately display the extent of the disease, as demonstrated by one of the RSNA exhibits by researchers from the George Washington University Medical Center in Washington, D.C. The authors used BSGI/MBI to detect DCIS lesions (ranging from 1 mm to several centimeters), to determine the extent of disease and varying pathological parameters. At the RSNA they will demonstrate the sensitivity of BSGI for DCIS to be 93 percent to 95 percent. "BSGI is a valuable tool that improves diagnostic accuracy, and complements other modalities, when included in the breast imaging protocol," said Jocelyn A. Rapelyea, MD, associate professor of radiology, George Washington University. "This modality is especially effective in assessing the extent of disease and assisting in surgical planning."

Another study that will be presented at the RSNA by investigators from Weinstein Imaging in Pittsburgh compares BSGI to mammography and ultrasound in patients undergoing diagnostic evaluation. The investigators demonstrate that BSGI is a useful tool for improving the detection of malignancies and note that the physiological information of BSGI is complementary to the anatomical depiction of the breast by mammography and ultrasound .

Source: Dilon Diagnostics